Obesity is a severe health problem in the modernized world and understanding the central nervous mechanisms underlying food-seeking behaviour and reward are at the forefront of medical research. Cannabinoid receptors have proven an efficient target to suppress hunger and weight gain by their pharmacological inactivation. A standard fasted protocol and a novel long-term home-cage observation system with free-feeding animals were used to assess the feeding behaviour of mice treated with the CB(1) antagonist AM251. Similarly, the effects of the phytocannabinoid Delta(9)-tetrahydrocannabivarin (Delta(9)-THCV), which behaves like a CB(1) antagonist, were also determined in free-feeding animals. AM251 suppressed food intake and weight gain in fasted and non-fasted animals. The suppression of food intake by AM251 (10 mg.kg(-1)) endured for a period of 6-8 h when administered acutely, and was continuous when injected for four consecutive days. Pure Delta(9)-THCV also induced hypophagia and weight reduction at doses as low as 3 mg.kg(-1). No rebound was observed on the following day with all drug groups returning to normal activity and feeding regimes. However, a Delta(9)-THCV-rich cannabis-extract failed to suppress food intake and weight gain, possibly due to residual Delta(9)-tetrahydrocannabinol (Delta(9)-THC) in the extract. This Delta(9)-THC effect was overcome by the co-administration of cannabidiol.

SYNTHETIC AND PLANT-DERIVED CANNABINOID RECEPTOR ANTAGONISTS SHOW HYPOPHAGIC PROPERTIES IN FASTED AND NON-FASTED MICE

FADDA, PAOLA;
2009

Abstract

Obesity is a severe health problem in the modernized world and understanding the central nervous mechanisms underlying food-seeking behaviour and reward are at the forefront of medical research. Cannabinoid receptors have proven an efficient target to suppress hunger and weight gain by their pharmacological inactivation. A standard fasted protocol and a novel long-term home-cage observation system with free-feeding animals were used to assess the feeding behaviour of mice treated with the CB(1) antagonist AM251. Similarly, the effects of the phytocannabinoid Delta(9)-tetrahydrocannabivarin (Delta(9)-THCV), which behaves like a CB(1) antagonist, were also determined in free-feeding animals. AM251 suppressed food intake and weight gain in fasted and non-fasted animals. The suppression of food intake by AM251 (10 mg.kg(-1)) endured for a period of 6-8 h when administered acutely, and was continuous when injected for four consecutive days. Pure Delta(9)-THCV also induced hypophagia and weight reduction at doses as low as 3 mg.kg(-1). No rebound was observed on the following day with all drug groups returning to normal activity and feeding regimes. However, a Delta(9)-THCV-rich cannabis-extract failed to suppress food intake and weight gain, possibly due to residual Delta(9)-tetrahydrocannabinol (Delta(9)-THC) in the extract. This Delta(9)-THC effect was overcome by the co-administration of cannabidiol.
phytocannabinoids; AM251; obesity
File in questo prodotto:
File Dimensione Formato  
Riedel 2009.pdf

Solo gestori archivio

Tipologia: versione editoriale
Dimensione 612.2 kB
Formato Adobe PDF
612.2 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11584/20108
Citazioni
  • ???jsp.display-item.citation.pmc??? 40
  • Scopus 101
  • ???jsp.display-item.citation.isi??? 92
social impact